Go here to read the rest:
Lotus Ventures Inc. Reports Fiscal 2021 Results
SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform
Vor Biopharma to Present at Jefferies and Goldman Sachs Investor Conferences
Originally posted here:
Vor Biopharma to Present at Jefferies and Goldman Sachs Investor Conferences
Chinook Therapeutics to Host Conference Call and Webcast Featuring BION-1301 Data Presented at the 58th ERA-EDTA Congress
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Read more from the original source:
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
OSE Immunotherapeutics Announces Dosing of the First Healthy Volunteer in Phase 1 Clinical Trial of its Multi-Variant Second-Generation COVID-19…
Pluristem Announces Uplisting to the Nasdaq Global Market®
Read this article:
Pluristem Announces Uplisting to the Nasdaq Global Market®
Immunicum AB (publ) Plans to Expand its Research and Process Development Facilities in Leiden, the Netherlands
GENFIT Informs its Shareholders of Certain Procedures for the Extraordinary General Meeting of January 13, 2021
Pacific Biosciences Announces Appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial Officer
Denali Therapeutics Announces Significant Program Progress and Expected Key Milestones in 2021 for Its Broad Therapeutic Portfolio in…
ImmuCell Announces Restructuring of its Bank Debt
Read the original here:
ImmuCell Announces Restructuring of its Bank Debt
Transactions in connection with share buyback program
Read the original here:
Transactions in connection with share buyback program
Operational and Financial Results for the Period Ended September 30, 2020
Mesoblast Corporate Update and Financial Results Webcast
See the rest here:
Mesoblast Corporate Update and Financial Results Webcast
Burning Rock Reports Third Quarter 2020 Financial Results
Read this article:
Burning Rock Reports Third Quarter 2020 Financial Results
Inventiva announces the publication of a scientific paper on the role of PPARs in the treatment of NASH in the medical journal Nature Review…
Obalon Announces Third Quarter 2020 Financial Results
Read more from the original source:
Obalon Announces Third Quarter 2020 Financial Results